|
1
|
Libby P, Buring JE, Badimon L, Hansson GK,
Deanfield J, Bittencourt MS, Tokgözoğlu L and Lewis EF:
Atherosclerosis. Nat Rev Dis Primers. 5:562019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Barquera S, Pedroza-Tobías A, Medina C,
Hernández-Barrera L, Bibbins-Domingo K, Lozano R and Moran AE:
Global overview of the epidemiology of atherosclerotic
cardiovascular disease. Arch Med Res. 46:328–338. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
GBD 2017 Causes of Death Collaborators:
Global, regional, and national age-sex-specific mortality for 282
causes of death in 195 countries and territories, 1980-2017: A
systematic analysis for the Global Burden of Disease Study 2017.
Lancet. 392:1736–1788. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Libby P, Ridker PM and Maseri A:
Inflammation and atherosclerosis. Circulation. 105:1135–1143. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Camaré C, Pucelle M, Nègre-Salvayre A and
Salvayre R: Angiogenesis in the atherosclerotic plaque. Redox Biol.
12:18–34. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nowbar AN, Gitto M, Howard JP, Francis DP
and Al-Lamee R: Mortality From Ischemic Heart Disease: Analysis of
Data From the World Health Organization and Coronary Artery Disease
Risk Factors From NCD Risk Factor Collaboration. Circ Cardiovasc
Qual Outcomes. 12:e0053752019. View Article : Google Scholar :
|
|
7
|
Klattenhoff CA, Scheuermann JC, Surface
LE, Bradley RK, Fields PA, Steinhauser ML, Ding H, Butty VL, Torrey
L, Haas S, et al: Braveheart, a long noncoding RNA required for
cardiovascular lineage commitment. Cell. 152:570–583. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pang KC, Frith MC and Mattick JS: Rapid
evolution of noncoding RNAs: Lack of conservation does not mean
lack of function. Trends Genet. 22:1–5. 2006. View Article : Google Scholar
|
|
9
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Haemmig S, Simion V, Yang D, Deng Y and
Feinberg MW: Long Noncoding RNAs in cardiovascular pathology,
diagnosis, and therapy. Curr Opin Cardiol. 32:7762017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Batista PJ and Chang HY: Long noncoding
RNAs: Cellular address codes in development and disease. Cell.
152:1298–1307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ulitsky I and Bartel DP: lincRNAs:
Genomics, evolution, and mechanisms. Cell. 154:26–46. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gong C and Maquat LE: lncRNAs
transactivate STAU1-mediated mRNA decay by duplexing with 3' UTRs
via Alu elements. Nature. 470:284–288. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yoon JH, Abdelmohsen K, Srikantan S, Yang
X, Martindale JL, De S, Huarte M, Zhan M, Becker KG and Gorospe M:
LincRNA-p21 suppresses target mRNA translation. Mol Cell.
47:648–655. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tripathi V, Ellis JD, Shen Z, Song DY, Pan
Q, Watt AT, Freier SM, Bennett CF, Sharma A, Bubulya PA, et al: The
nuclear-retained noncoding RNA MALAT1 regulates alternative
splicing by modulating SR splicing factor phosphorylation. Mol
Cell. 39:925–938. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chowdhary A, Satagopam V and Schneider R:
Long non-coding RNAs: mechanisms, experimental, and computational
approaches in identification, characterization, and their biomarker
potential in cancer. Front. Genet. 12:6496192021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Botti G, De Chiara A, Di Bonito M, Cerrone
M, Malzone MG, Collina F and Cantile M: Noncoding RNAs within the
HOX gene network in tumor pathogenesis and progression. J Cell
Physiol. 234:395–413. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang X, Gao Y, Wu H, Mao Y and Qi Y:
LncRNA HOX transcript antisense RNA mitigates cardiac function
injury in chronic heart failure via regulating microRNA-30a-5p to
target KDM3A. J Cell Mol Med. 26:1473–1485. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang B, Ma L and Wang J: LncRNA HOTTIP
Knockdown Attenuates Acute Myocardial Infarction via Regulating
miR-92a-2/c-Met Axis. Cardiovasc Toxicol. 22:352–364. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fan H, Shao H and Gao X: Long Non-Coding
RNA HOTTIP is elevated in patients with sepsis and promotes cardiac
dysfunction. Immunol Invest. 51:2086–2096. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gao L, Wang X, Guo S, Xiao L, Liang C,
Wang Z, Li Y, Liu Y, Yao R, Liu Y and Zhang Y: LncRNA HOTAIR
functions as a competing endogenous RNA to upregulate SIRT1 by
sponging miR-34a in diabetic cardiomyopathy. J Cell Physiol.
234:4944–4958. 2019. View Article : Google Scholar
|
|
22
|
Wang Y, Dang Y, Liu J and Ouyang X: The
function of homeobox genes and lncRNAs in cancer. Oncol. Lett.
12:1635–1641. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
De Kumar B and Krumlauf R: HOXs and
lincRNAs: Two sides of the same coin. Sci Adv. 2:e15014022016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dasen JS: Long noncoding RNAs in
development: Solidifying the Lncs to Hox gene regulation. Cell Rep.
5:1–2. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Maguire EM, Pearce SWA and Xiao Q: Foam
cell formation: A new target for fighting atherosclerosis and
cardiovascular disease. Vascul Pharmacol. 112:54–71. 2019.
View Article : Google Scholar
|
|
26
|
Huang C, Hu YW, Zhao JJ, Ma X, Zhang Y,
Guo FX, Kang CM, Lu JB, Xiu JC, Sha YH, et al: Long Noncoding RNA
HOXC-AS1 Suppresses Ox-LDL-Induced Cholesterol Accumulation Through
Promoting HOXC6 Expression in THP-1 Macrophages. DNA Cell Biol.
35:722–729. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou Q, Kong D, Li W, Shi Z, Liu Y, Sun R,
Ma X, Qiu C, Liu Z, Hou Y and Jiang J: LncRNA HOXB-AS3 binding to
PTBP1 protein regulates lipid metabolism by targeting SREBP1 in
endometrioid carcinoma. Life Sci. 320:1215122023. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gariani K and Jornayvaz FR:
Pathophysiology of NASH in endocrine diseases. Endocr Connect.
10:R52–R65. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Geovanini GR and Libby P: Atherosclerosis
and inflammation: Overview and updates. Clin Sci (Lond).
132:1243–1252. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Woo CJ and Kingston RE: HOTAIR lifts
noncoding RNAs to new levels. Cell. 129:1257–1259. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pang JL, Wang JW, Hu PY, Jiang JS and Yu
C: HOTAIR alleviates ox-LDL-induced inflammatory response in
Raw264.7 cells via inhibiting NF-κB pathway. Eur Rev Med Pharmacol
Sci. 22:6991–6998. 2018.PubMed/NCBI
|
|
32
|
Liu J, Huang GQ and Ke ZP: Silence of long
intergenic noncoding RNA HOTAIR ameliorates oxidative stress and
inflammation response in ox-LDL-treated human macrophages by
upregulating miR-330-5p. J Cell Physiol. 234:5134–5142. 2019.
View Article : Google Scholar
|
|
33
|
Lu W, Zhu L, Ruan ZB, Wang MX, Ren Y and
Li W: HOTAIR promotes inflammatory response after acute myocardium
infarction by upregulating RAGE. Eur Rev Med Pharmacol Sci.
22:7423–7430. 2018.PubMed/NCBI
|
|
34
|
Sen R and Baltimore D: Inducibility of
kappa immunoglobulin enhancer-binding protein Nf-kappa B by a
posttranslational mechanism. Cell. 47:921–928. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pamukcu B, Lip GY and Shantsila E: The
nuclear factor-kappa B pathway in atherosclerosis: A potential
therapeutic target for atherothrombotic vascular disease. Thromb
Res. 128:117–123. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang G, Wang Q and Xu W: Effects of Long
Noncoding RNA HOTAIR Targeting miR-138 on Inflammatory Response and
Oxidative Stress in Rat Cardiomyocytes Induced by Hypoxia and
Reoxygenation. Dis Markers. 2021:42732742021. View Article : Google Scholar :
|
|
37
|
Zhu X, Liu Y, Yu J, Du J, Guo R, Feng Y,
Zhong G, Jiang Y and Lin J: LncRNA HOXA-AS2 represses endothelium
inflammation by regulating the activity of NF-κB signaling.
Atherosclerosis. 281:38–46. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhu X, Chen D, Liu Y, Yu J, Qiao L, Lin S,
Chen D, Zhong G, Lu X, Wang Y, et al: Long Noncoding RNA HOXA-AS3
Integrates NF-κB Signaling To Regulate Endothelium Inflammation.
Mol Cell Biol. 39:e00139–19. 2019. View Article : Google Scholar :
|
|
39
|
Jin QS, Huang LJ, Zhao TT, Yao XY, Lin LY,
Teng YQ, Kim SH, Nam MS, Zhang LY and Jin YJ: HOXA11-AS regulates
diabetic arteriosclerosis-related inflammation via PI3K/AKT
pathway. Eur Rev Med Pharmacol Sci. 22:6912–6921. 2018.PubMed/NCBI
|
|
40
|
Obaid M, Udden SMN, Deb P, Shihabeddin N,
Zaki MH and Mandal SS: LncRNA HOTAIR regulates
lipopolysaccharide-induced cytokine expression and inflammatory
response in macrophages. Sci Rep. 8:156702018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Obaid M, Udden SMN, Alluri P and Mandal
SS: LncRNA HOTAIR regulates glucose transporter Glut1 expression
and glucose uptake in macrophages during inflammation. Sci Rep.
11:2322021. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ni SY, Xu WT, Liao GY, Wang YL and Li J:
LncRNA HOTAIR Promotes LPS-Induced inflammation and apoptosis of
cardiomyocytes via Lin28-Mediated PDCD4 Stability. Inflammation.
44:1452–1463. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xiao W, Jia Z, Zhang Q, Wei C, Wang H and
Wu Y: Inflammation and oxidative stress, rather than hypoxia, are
predominant factors promoting angiogenesis in the initial phases of
atherosclerosis. Mol Med Rep. 12:3315–3322. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wu K, Liu F, Wu W, Chen Y, Wu H and Zhang
W: Long non-coding RNA HOX transcript antisense RNA (HOTAIR)
suppresses the angiogenesis of human placentation by inhibiting
vascular endothelial growth factor A expression. Reprod Fertil Dev.
31:377–385. 2019. View Article : Google Scholar
|
|
45
|
Di Stefano R, Felice F and Balbarini A:
Angiogenesis as risk factor for plaque vulnerability. Curr Pharm
Des. 15:1095–1106. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang Y, Mao J, Li X, Wang B and Zhou X:
lncRNA HOTAIR mediates OGD/R-induced cell injury and angiogenesis
in a EZH2-dependent manner. Exp Ther Med. 23:992022. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bennett MR, Sinha S and Owens GK: Vascular
smooth muscle cells in atherosclerosis. Circ Res. 118:692–702.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Davignon J and Ganz P: Role of endothelial
dysfunction in atherosclerosis. Circulation. 109(23 Suppl 1):
III27–III32. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sun GB, Qin M, Ye JX, Pan RL, Meng XB,
Wang M, Luo Y, Li ZY, Wang HW and Sun XB: Inhibitory effects of
myricitrin on oxidative stress-induced endothelial damage and early
atherosclerosis in ApoE-/-mice. Toxicol Appl Pharmacol.
271:114–126. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chi K, Zhang J, Sun H, Liu Y, Li Y, Yuan T
and Zhang F: Knockdown of lncRNA HOXA-AS3 suppresses the
progression of atherosclerosis via Sponging miR-455-5p. Drug Des
Devel Ther. 14:3651–3662. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Choi BK, Fujiwara K, Dayaram T, Darlington
Y, Dickerson J, Goodell MA and Donehower LA: WIP1 dephosphorylation
of p27Kip1 serine 140 destabilizes p27Kip1
and reverses anti-proliferative effects of ATM phosphorylation.
Cell Cycle. 19:479–491. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Gao F, Wang XC, Luo ZD, Hu GQ, Ma MQ,
Liang Y, Xu BL and Lin XH: LncRNA HOXA11-AS promotes vascular
endothelial cell injury in atherosclerosis by regulating the
miR-515-5p/ROCK1 axis. ESC Heart Fail. 9:2259–2271. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Peng Y, Meng K, Jiang L, Zhong Y, Yang Y,
Lan Y, Zeng Q and Cheng L: Thymic stromal lymphopoietin-induced
HOTAIR activation promotes endothelial cell proliferation and
migration in atherosclerosis. Biosci Rep. 37:BSR201703512017.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Liao B, Chen R, Lin F, Mai A, Chen J, Li
H, Xu Z and Dong S: Long noncoding RNA HOTTIP promotes endothelial
cell proliferation and migration via activation of the
Wnt/β-catenin pathway. J Cell Biochem. 119:2797–2805. 2018.
View Article : Google Scholar
|
|
55
|
Dai Z, Liu X, Zeng H and Chen Y: Long
noncoding RNA HOTAIR facilitates pulmonary vascular endothelial
cell apoptosis via DNMT1 mediated hypermethylation of Bcl-2
promoter in COPD. Respir Res. 23:3562022. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Guo X, Liu Y, Zheng X, Han Y and Cheng J:
HOTTIP knockdown inhibits cell proliferation and migration via
regulating miR-490-3p/HMGB1 axis and PI3K-AKT signaling pathway in
ox-LDL-induced VSMCs. Life Sci. 248:1174452020. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Xue H, Wang B and Xue YS: LncRNA HOTAIR
regulates the proliferation and apoptosis of vascular smooth muscle
cells through targeting miRNA-130b-3p/PPARα axis. Eur Rev Med
Pharmacol Sci. 23:10989–10995. 2019.PubMed/NCBI
|
|
58
|
Shen D, Chen Q, Li J, Wang S, Song H and
Wang F: Clinical Value of Long Non-Coding RNA HOTAIR in carotid
artery stenosis and its role in vascular smooth muscle cell
proliferation. Crit Rev Eukaryot Gene Expr. 33:15–23. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Fan TT, Liu YX, Wang XC, Xu BL, Chen ZC,
Lu HA and Zhang M: LncRNA HOXA-AS2 accelerates the proliferation
and migration and inhibits the apoptosis of vascular smooth muscle
cells by absorbing miRNA-877-3p. Eur Rev Med Pharmacol Sci.
24:362–368. 2020.PubMed/NCBI
|
|
60
|
Ou M, Chu Y, Zhang Q, Zhao H and Song Q:
HOXA cluster antisense RNA 2 elevates KIAA1522 expression through
microRNA-520d-3p and insulin like growth factor 2 mRNA binding
protein 3 to promote the growth of vascular smooth muscle cells in
thoracic aortic aneurysm. ESC Heart Fail. 9:2955–2966. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Lai Y, He S, Ma L, Lin H, Ren B, Ma J, Zhu
X and Zhuang S: HOTAIR functions as a competing endogenous RNA to
regulate PTEN expression by inhibiting miR-19 in cardiac
hypertrophy. Mol Cell Biochem. 432:179–187. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Pan SC, Cui HH and Qiu CG: HOTAIR promotes
myocardial fibrosis through regulating URI1 expression via Wnt
pathway. Eur Rev Med Pharmacol Sci. 22:6983–6990. 2018.PubMed/NCBI
|
|
63
|
Tan W, Wang K, Yang X, Wang K, Wang N and
Jiang TB: LncRNA HOTAIR promotes myocardial fibrosis in atrial
fibrillation through binding with PTBP1 to increase the stability
of Wnt5a. Int J Cardiol. 369:21–28. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Jiang J, Xu ST and Ren K: LncRNA HOTAIR
promotes myocardial fibrosis by suppressing miR-124. Int J Cardiol.
374:942023. View Article : Google Scholar
|
|
65
|
Wang J, Liu X, Zhuang Q, Pan R, Zou L, Cen
Z and Tang L: Long noncoding RNA homeobox A11 antisense promotes
transforming growth factor β1induced fibrogenesis in cardiac
fibroblasts. Mol Med Rep. 19:2817–2824. 2019.PubMed/NCBI
|
|
66
|
Sun Y and Hu ZQ: LncRNA HOTAIR aggravates
myocardial ischemia-reperfusion injury by sponging microRNA-126 to
upregulate SRSF1. Eur Rev Med Pharmacol Sci. 24:9046–9054.
2020.PubMed/NCBI
|
|
67
|
Wang B, Wu Q, Liao J, Zhang S, Liu H, Yang
C, Dong Q, Zhao N, Huang Z, Guo K and Du Y: Propofol induces
cardioprotection against ischemia-reperfusion injury via
suppression of transient receptor potential vanilloid 4 channel.
Front Pharmacol. 10:11502019. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Chen J, Li X, Zhao F and Hu Y:
HOTAIR/miR-17-5p axis is involved in the propofol-mediated
cardioprotection against ischemia/reperfusion injury. Clin Interv
Aging. 16:621–632. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Liu Z, Liu Y, Zhu Y and Gong J:
HOTAIR/miRNA-1/Cx43: A potential mechanism for treating myocardial
ischemia-reperfusion injury. Int J Cardiol. 308:112020. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Wang Z, Luo W, Zhong P, Feng Y and Wang H:
lncRNA HAGLR modulates myocardial ischemia-reperfusion injury in
mice through regulating miR-133a-3p/MAPK1 axis. Open Med (Wars).
17:1299–1307. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Chouchani ET, Pell VR, James AM, Work LM,
Saeb-Parsy K, Frezza C, Krieg T and Murphy MP: A Unifying mechanism
for mitochondrial superoxide production during ischemia-reper
fusion injury. Cell Metab. 23:2542632016. View Article : Google Scholar
|
|
72
|
Fang J, Zheng W, Hu P and Wu J:
Investigating the effect of lncRNA HOTAIR on apoptosis induced by
myocardial ischemia-reperfusion injury. Mol Med Rep. 23:1692021.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Yao J, Ma R, Wang C and Zhao G:
LncRNA-HOTAIR inhibits H9c2 apoptosis after acute myocardial
infarction via miR-206/FN1 axis. Biochem Genet. 60:1781–1792. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Zhao X, Wang C, Liu M, Meng F and Liu K:
LncRNA FENDRR servers as a possible marker of essential
hypertension and regulates human umbilical vein endothelial cells
dysfunction via miR-423-5p/Nox4 Axis. Int J Gen Med. 15:2529–2540.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Li R, Yu X, Chen Y, Xiao M, Zuo M, Xie Y,
Yang Z and Kuang D: Association of lncRNA PVT1 gene polymorphisms
with the risk of essential hypertension in Chinese Population.
Biomed Res Int. 2022:99769092022.PubMed/NCBI
|
|
76
|
Peng W, Cao H, Liu K, Guo C, Sun Y, Qi H,
Liu Z, Xie Y, Liu X, Li B and Zhang L: Identification of
lncRNA-NR_104160 as a biomarker and construction of a
lncRNA-related ceRNA network for essential hypertension. Am J
Transl Res. 12:6060–6075. 2020.PubMed/NCBI
|
|
77
|
Yin L, Yao J, Deng G, Wang X, Cai W and
Shen J: Identification of candidate lncRNAs and circRNAs regulating
WNT3/β-catenin signaling in essential hypertension. Aging (Albany
NY). 12:8261–8288. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Fang G, Qi J, Huang L and Zhao X: LncRNA
MRAK048635_P1 is critical for vascular smooth muscle cell function
and phenotypic switching in essential hypertension. Biosci Rep.
39:BSR201822292019. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Ali MA, Shaker OG, Khalifa AA, Ezzat EM,
Elghobary HA, Abdel Mawla TS, Elkhateeb AF, Elebiary AMA and Elamir
AM: LncRNAs NEAT1, HOTAIR, and GAS5 expression in hypertensive and
non-hypertensive associated cerebrovascular stroke patients, and
its link to clinical characteristics and severity score of the
disease. Noncoding RNA Res. 8:96–108. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Lau EMT, Giannoulatou E, Celermajer DS and
Humbert M: Epidemiology and treatment of pulmonary arterial
hypertension. Nat Rev Cardiol. 14:603–614. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Zhang ZQ, Zhu SK, Wang M, Wang XA, Tong
XH, Wan JQ and Ding JW: New progress in diagnosis and treatment of
pulmonary arterial hypertension. J Cardiothorac Surg. 17:2162022.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Rabinovitch M: Pathobiology of pulmonary
hypertension. Annu Rev Pathol. 2:369–399. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Li ZK, Gao LF, Zhu XA and Xiang DK: LncRNA
HOXA-AS3 Promotes the Progression of Pulmonary Arterial
Hypertension through Mediation of miR-675-3p/PDE5A Axis. Biochem
Genet. 59:1158–1172. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Zhang H, Liu Y, Yan L, Wang S, Zhang M, Ma
C, Zheng X, Chen H and Zhu D: Long noncoding RNA Hoxaas3
contributes to hypoxia-induced pulmonary artery smooth muscle cell
proliferation. Cardiovasc Res. 115:647–657. 2019. View Article : Google Scholar
|
|
85
|
Shi X, Shao X, Liu B, Lv M, Pandey P, Guo
C, Zhang R and Zhang Y: Genome-wide screening of functional long
noncoding RNAs in the epicardial adipose tissues of atrial
fibrillation. Biochim Biophys Acta Mol Basis Dis. 1866:1657572020.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Qian C, Li H, Chang D, Wei B and Wang Y:
Identification of functional lncRNAs in atrial fibrillation by
integrative analysis of the lncRNA-mRNA network based on competing
endogenous RNAs hypothesis. J Cell Physiol. 234:11620–11630. 2019.
View Article : Google Scholar
|
|
87
|
Jiang Y, Mo H, Luo J, Zhao S, Liang S,
Zhang M and Yuan J: HOTAIR is a potential novel biomarker in
patients with congenital heart diseases. Biomed Res Int.
2018:28506572018. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Gao L, Liu Y, Guo S, Yao R, Wu L, Xiao L,
Wang Z, Liu Y and Zhang Y: Circulating Long Noncoding RNA HOTAIR is
an Essential Mediator of Acute Myocardial Infarction. Cell Physiol
Biochem. 44:1497–1508. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Dai W, Chao X, Li S, Zhou S, Zhong G and
Jiang Z: Long Noncoding RNA HOTAIR Functions as a Competitive
Endogenous RNA to Regulate Connexin43 Remodeling in Atrial
Fibrillation by Sponging MicroRNA-613. Cardiovasc Ther.
2020:59253422020. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Jin Z, Shen H, Cha W, Xia H and Liu L:
Predictive value of using plasma long non-coding RNAs ANRIL and
HOXA11-AS for in-stent restenosis. Exp Ther Med. 23:1152022.
View Article : Google Scholar : PubMed/NCBI
|
